Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in apoE-deficient mice

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Reifenberg, Kurt ^a   Cheng, Fei ^a   Orning, Carolin ^a   Crain, Jeanine ^a   Küpper, Ines ^a   Wiese, Elena ^a   Protschka, Martina ^b   Blessing, Manfred ^b   Lackner, Karl J ^a   Torzewski, Michael ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL COUNT; CELL SPECIFICITY; CONTROLLED STUDY; DIET; DISEASE DURATION; EMBRYO; FEMALE; GENE; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOMODULATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE FIBER; TGF BETA1 GENE; WESTERN TYPE DIET;

ANIMALS; APOLIPOPROTEINS E; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PLAQUE, ATHEROSCLEROTIC; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS; WHITE TIP DIE-BACK PHYTOPLASMA;

EID: 84864026952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040990     Document Type: Article

References (50)

1. Blobe GC, Schiemann WP, Lodish HF, (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
2. Massagué J, Blain SW, Lo RS, (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
3. Bobik A, (2006) Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26: 1712-1720.
4. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC, (1995) Release and activation of platelet latent TGF-beta in blood clots during dissolution withplasmin. Nat Med 1: 932-937.
5. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K, (2002) Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 13: 139-143.
6. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, et al. (2001) Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89: 930-934.
7. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, et al. (2002) Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22: 975-982.
8. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, et al. (2009) TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 29: 1251-1257.
9. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, et al. (2003) Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102: 4052-4058.
10. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, et al. (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 112: 1342-1350.
11. Li MO, Sanjabi S, Flavell RA, (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25(3): 455-471.
12. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, et al. (1987) Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A 84: 6020-6024.
13. Nunes I, Shapiro RL, Rifkin DB, (1995) Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol 155: 1450-1459.
14. Gratchev A, Kzhyshkowska J, Kannookadan S, Ochsenreiter M, Popova A, et al. (2008) Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J Immunol 180: 6553-6565.
15. Sharples K, Plowman GD, Rose TM, Twardzik DR, Purchio AF, (1987) Cloning and sequence analysis of simian transforming growth factor-beta cDNA. DNA 6: 239-244.
16. Horvai A, Palinski W, Wu H, Moulton KS, Kalla K, et al. (1995) Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A 92: 5391-5395.
17. Wilson K, Fry GL, Chappell DA, Sigmund CD, Medh JD, (2001) Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol 21: 1809-1815.
18. Petkov PM, Cassell MA, Sargent EE, Donnelly CJ, Robinson P, et al. (2004) Development of a SNP genotyping panel for genetic monitoring of the laboratory mouse. Genomics 83: 902-911.
19. Mach F, Schönbeck U, Sukhova G, Atkinson E, Libby P, (1998) Reduction of atherosclerosis in mic by inhibition of CD40 signalling. Nature 394(6689): 200-203.
20. Lehr HA, Sagban TA, Ihling C, Zähringer U, Hungerer KD, et al. (2001) Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104(8): 914-920.
21. Torzewski M, Ochsenhirt V, Kleschyov AL, Oelze M, Daiber A, et al. (2007) Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27: 850-857.
22. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown CM, (1997) Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45: 1559-1565.
23. Lehr H, van der Loos CM, Teeling P, Gown AM, (1999) Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 47: 119-126.
24. Hansson J, Munn M, Rupp WD, Kahn R, Wood RD, (1989) Localization of DNA repair synthesis by human cell extracts to a short region at the site of a lesion. J Biol Chem 264(36): 21788-21792.
25. Wan YY, Flavell RA, (2007) 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Re 220: 199-213.
26. Song L, Leung C, Schindler C, (2001) Lymphocytes are important in early atherosclerosis. J Clin Invest 108: 251-259.
27. Fyfe AI, Qiao JH, Lusis AJ, (1994) Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 94: 2516-2520.
28. Zhou X, Nicoletti A, Elhage R, Hansson GK, (2000) Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102: 2919-2922.
29. Zhou X, Robertson AK, Rudling M, Parini P, Hansson GK, (2005) Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 96: 427-434.
30. Reardon CA, Blachowicz L, White T, Cabana V, Wang Y, et al. (2001) Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1011-1016.
31. Daugherty A, Puré E, Delfel-Butteiger D, Chen S, Leferovich J, et al. (1997) The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest 100: 1575-1580.
32. Dansky HM, Charlton SA, Harper MM, Smith JD, (1997) T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A 94: 4642-4646.
33. Robertson AK, Hansson GK, (2006) T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 26(11): 2421-2432.
34. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, et al. (1999) Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 99(22): 2883-2891.
35. Tsunawaki S, Sporn M, Ding A, (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334: 260-262.
36. Meir KS, Leitersdorf E, (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24: 1006-1014.
37. Getz GS, Reardon CA, (2006) Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 26: 242-249.
38. Maeda N, (2011) Development of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31: 1957-1962.
39. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM, (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20(5): 1262-1275.
40. Owens GK, Geisterfer AA, Yang YW, Komoriya A, (1988) Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107: 771-780.
41. Björkerud S, (1991) Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb 11: 892-902.
42. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
43. Li D, Liu Y, Chen J, Velchala N, Amani F, et al. (2006) Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice. Biochem Biophys Res Commun 344: 701-707.
44. Brand T, MacLellan WR, Schneider MD, (1993) A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J Biol Chem 268: 11500-11503.
45. Gratchev A, Kzhyshkowska J, Kannookadan S, Ochsenreiter M, Popova A, et al. (2008) Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J Immunol 180: 6553-6565.
46. Tsunawaki S, Sporn M, Ding A, Nathan C, (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334: 260-262.
47. McCartney-Francis NL, Wahl SM, (1994) Transforming growth factor beta: a matter of life and death. J Leukoc Biol 55: 401-409.
48. McCaffrey TA, (2000) TGF-betas and TGF-beta receptors in atherosclerosis. Cytokine Growth Factor Rev 11: 103-114.
49. Bot PT, Grundmann S, Goumans MJ, de Kleijn D, Moll F, et al. (2011) Forkhead box protein P1 as a downstream target of transforming growth factor-ß induces collagen synthesis and correlates with a more stable plaque phenotype. Atherosclerosis 218(1): 33-43.
50. Shi C, Sakuma M, Mooroka T, Liscoe A, Gao H, et al. (2008) Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 112(12): 4699-4711.